blog hero 7-1.png


David Shenberger

David Shenberger is CAI's Vice President, North America. He is a certified Project Management Professional (PMP) and has over 20 years’ experience in the pharmaceutical and biotechnology industries specifically in the areas of process control systems and computer system validation.
Find me on:

Recent Posts

Optimizing Time to Market

By David Shenberger, June 20, 2017

In the biotech industry today, mergers, acquisitions, and joint ventures are announced daily. Startup companies with viable molecules must decide early how they are going to get a drug into trials and eventually to the marketplace as rapidly as possible. Contract research organizations (CROs), contract development and manufacturing companies (CDMOs), and dedicated contract manufacturing organizations (CMOs) all offer options for the specific expertise needed to complete the research, product development, and process development necessary to successfully manufacture a new drug entity.

Read More
How to Understand ASTM E2500